Article

AMO names new CFO, announces other personnel changes

Santa Ana, CA- Michael J. Lambert has joined Advanced Medical Optics Inc. (AMO) as chief financial officer (CFO).

Santa Ana, CA- Michael J. Lambert has joined Advanced Medical Optics Inc. (AMO) as chief financial officer (CFO). He will oversee the company’s finance, accounting, tax, treasury, and information technology functions and will report directly to James V. Mazzo, AMO chairman, president, and chief executive officer.

Most recently, Lambert was senior vice president (VP) and CFO for Quest Software Inc. Other previous positions include executive VP and CFO at Quantum Corp., senior VP and CFO at Nervewire Inc., and VP and CFO of the Lucent Technologies InterNetworking Systems Division.

In the role of CFO, Lambert succeeds Richard “Randy” A. Meier, formerly CFO and chief operating officer (COO). Meier will continue as COO, managing AMO’s eye-care business and global manufacturing and supply chain operations. Additionally, he will assume responsibility for managing the company’s cataract/implant business and global customer services function.

C. Russell Trenary III, previously president of the company’s cataract/implant business, has been named executive VP of global public policy and medical education, encompassing all of AMO’s businesses and product lines.

Both Meier and Trenary will continue to report to Mazzo.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.